Zacks Investment Research
07 Aug 2026, 14:46 UTC · 1h ago
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Aug 2026, 14:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Innospec Inc. reported Q2 2026 adjusted earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 by 21%. — A significant earnings beat typically triggers positive short-term price movement for the specific ticker.
+0.40Innospec's Q2 2026 revenues rose 11.8% year over year to $491.4 million, surpassing the consensus estimate of $462.4 million by 6.4%. — Top-line growth and a revenue beat signal strong demand across the company's business segments.
+0.30The Oilfield Services segment saw operating income increase by 40.3% to $8.7 million, driven by a drag-reducing agent plant expansion. — High growth in a specific segment indicates successful capital expenditure and expansion strategy.
+0.20Continue reading
6 related stories
Top 2 movers · tap to explore
Performance Chemicals revenues grew 9.5% despite a 2% decline in volume, supported by positive price/mix and currency contributions. — While revenue grew, the decline in volume suggests a reliance on pricing power rather than organic demand growth.
+0.10Which stocks this story touches
The company beat both earnings and revenue consensus estimates with growth across all business segments.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
2h ago
